, Part I, Item 1A. Risk Factors, and Part II, Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations, but are also contained elsewhere in this Annual Report. In some cases, you can identify forward-looking statements by the words may, might, will, could, would, should, expect, intend, plan, objective, anticipate, believe, estimate, predict, project, potential, continue and ongoing, or the negative of these terms, or other comparable terminology intended to i...
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-27 | 2024-12-31 | 0000950170-25-046134 | EDGAR | 81K words |
| 2024-03-12 | 2023-12-31 | 0000950170-24-030126 | EDGAR | — |
| 2023-03-14 | 2022-12-31 | 0000950170-23-007732 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0000950170-22-003468 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001564590-21-013027 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001564590-20-010810 | EDGAR | — |
| 2019-03-15 | 2018-12-31 | 0001564590-19-007887 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001564590-18-006055 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004643 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001193125-25-282949 | EDGAR | 23K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105812 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072568 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125425 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095489 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057834 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0000950170-23-063025 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042469 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021746 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023525 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0000950170-22-017137 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009687 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-12-29 | 0001193125-25-332152 | EDGAR | 4K words |
| 2025-12-08 | 0001193125-25-311305 | EDGAR | — |
| 2025-11-25 | 0001193125-25-297177 | EDGAR | — |
| 2025-10-07 | 0001193125-25-233470 | EDGAR | — |
| 2025-09-11 | 0001193125-25-200747 | EDGAR | — |
| 2025-09-11 | 0000950170-25-114089 | EDGAR | — |
| 2025-09-08 | 0000950170-25-113362 | EDGAR | — |
| 2025-09-03 | 0001193125-25-194994 | EDGAR | — |
| 2025-08-14 | 0000950170-25-108846 | EDGAR | — |
| 2025-07-17 | 0000950170-25-096438 | EDGAR | — |
188 total filings indexed. 157 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001539029 |
| Ticker | CLSDQ |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report